Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06344338
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2024-03-19
Brief Title:
Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
Sponsor:
Xuanwu Hospital Beijing
Organization:
Xuanwu Hospital Beijing
Study Overview
Official Title:
Application of Targeting Transcranial Direct Current Stimulation tDCS Stimulation in the Treatment of Refractory Status Epilepticus
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
tDCS
Brief Summary:
The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus
Detailed Description:
After being informed about the study and potential risks the recruited patients giving written informed consent will be determined of the eligibility for study entry The patients who meet the eligibility requirements will be randomized in a 11 ratio to undergo targeting tDCS stimulation up to 10 times or sham stimulation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None